Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibody
Biotech
Roivant’s midstage asset fails to show benefit in lung disease
Given the results, Kinevant is terminating development of the candidate—dubbed namilumab—as a potential sarcoidosis treatment.
Gabrielle Masson
Dec 3, 2024 10:32am
Jade pockets Aerovate in reverse merger
Oct 31, 2024 3:03pm
Awaiting regulator verdict, Innovent posts latest psoriasis win
Oct 29, 2024 9:50am
AstraZeneca IL-33 drug fails to improve COPD breathing in ph. 2
Sep 8, 2024 9:45am
AbbVie axes Alzheimer's program amid 'evolving landscape'
Jul 25, 2024 10:49am
Marea ropes in $190M for clinical-stage cardiometabolic program
Jun 18, 2024 7:00am
